CODX Co-Diagnostics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CODX

Price (delayed)

$1.4

Market cap

$43.29M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.45

Enterprise value

$20.67M

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The Company's technology is utilized for tests that are designed using ...

Highlights
Co-Diagnostics's quick ratio has surged by 149% YoY and by 39% QoQ
The company's debt fell by 17% QoQ
CODX's net income has dropped by 194% since the previous quarter and by 139% year-on-year
CODX's EPS has dropped by 192% since the previous quarter and by 135% year-on-year
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://codiagnostics.com
Peers: PAVM PACB

Key stats

What are the main financial stats of CODX
Market
Shares outstanding
30.92M
Market cap
$43.29M
Enterprise value
$20.67M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.38
Price to sales (P/S)
1.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.6
Earnings
Revenue
$34.22M
EBIT
-$18.85M
EBITDA
-$17.53M
Free cash flow
$5.14M
Per share
EPS
-$0.45
Free cash flow per share
$0.16
Book value per share
$3.7
Revenue per share
$1.09
TBVPS
$3.06
Balance sheet
Total assets
$123.09M
Total liabilities
$8.57M
Debt
$347,917
Equity
$114.52M
Working capital
$88.86M
Liquidity
Debt to equity
0
Current ratio
23.94
Quick ratio
21.89
Net debt/EBITDA
1.29
Margins
EBITDA margin
-51.2%
Gross margin
84%
Net margin
-41.6%
Operating margin
-78.8%
Efficiency
Return on assets
-9.4%
Return on equity
-10.5%
Return on invested capital
-56.3%
Return on capital employed
-15.8%
Return on sales
-55.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CODX stock price

How has the Co-Diagnostics stock price performed over time
Intraday
0.72%
1 week
-26.32%
1 month
-51.22%
1 year
-75.67%
YTD
-44.44%
QTD
-44.44%

Financial performance

How have Co-Diagnostics's revenue and profit performed over time
Revenue
$34.22M
Gross profit
$28.74M
Operating income
-$26.98M
Net income
-$14.24M
Gross margin
84%
Net margin
-41.6%
CODX's net income has dropped by 194% since the previous quarter and by 139% year-on-year
CODX's operating income has plunged by 159% YoY
The company's gross profit has shrunk by 67% YoY and by 37% QoQ
The revenue has plunged by 65% YoY and by 36% from the previous quarter

Growth

What is Co-Diagnostics's growth rate over time

Valuation

What is Co-Diagnostics stock price valuation
P/E
N/A
P/B
0.38
P/S
1.29
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.6
CODX's EPS has dropped by 192% since the previous quarter and by 135% year-on-year
The P/B is 98% below the 5-year quarterly average of 19.8 and 65% below the last 4 quarters average of 1.1
The equity has declined by 15% since the previous quarter and by 15% year-on-year
The P/S is 100% below the 5-year quarterly average of 301.1 and 41% below the last 4 quarters average of 2.2
The revenue has plunged by 65% YoY and by 36% from the previous quarter

Efficiency

How efficient is Co-Diagnostics business performance
The ROA has plunged by 199% from the previous quarter and by 128% YoY
CODX's return on equity has dropped by 197% since the previous quarter and by 129% year-on-year
CODX's return on invested capital has dropped by 169% since the previous quarter and by 122% year-on-year

Dividends

What is CODX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CODX.

Financial health

How did Co-Diagnostics financials performed over time
The current ratio has soared by 162% YoY and by 41% from the previous quarter
Co-Diagnostics's quick ratio has surged by 149% YoY and by 39% QoQ
The company's debt is 100% lower than its equity
The company's debt fell by 17% QoQ
The equity has declined by 15% since the previous quarter and by 15% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.